A new drug called olpasiran can dramatically lower a harmful type of cholesterol called lipoprotein(a) in people with heart disease — at the highest dose, it doesn’t just reduce it, it nearly wipes...
66
0
Evidence from Studies
Supporting (1)
66
Community contributions welcome
66
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease.
Randomized Controlled Trial
Human
2022 Nov 17Contradicting (0)
0
Community contributions welcome
No contradicting evidence found
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.